Fundraising Fox뉴로벤티
1 known investors
Find your way into 뉴로벤티
Sign up to see every warm intro you have to 뉴로벤티
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 뉴로벤티 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeuroVenti is a biotech company developing neuroprotective and therapeutic agents for neuronal and central nervous system disorders, including a drug candidate (NV01-A02) for autism spectrum disorder currently in domestic Phase 2 clinical trials. It also offers preclinical CDRO services such as candidate discovery, preclinical research consulting, and efficacy and safety evaluation.
Investors · 1
Frequently asked questions
- What does 뉴로벤티 do?
- NeuroVenti is a biotech company developing neuroprotective and therapeutic agents for neuronal and central nervous system disorders, including a drug candidate (NV01-A02) for autism spectrum disorder currently in domestic Phase 2 clinical trials. It also offers preclinical CDRO services such as candidate discovery, preclinical research consulting, and efficacy and safety evaluation.
- Who are 뉴로벤티's investors?
- 뉴로벤티's investors include Hyundai Venture Investment Corporation.